Free Trial

Boston Scientific (BSX) Competitors

Boston Scientific logo
$104.48 +1.29 (+1.25%)
As of 10:16 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BSX vs. ABT, ISRG, SYK, MDT, BDX, EW, IDXX, RMD, DXCM, and STE

Should you be buying Boston Scientific stock or one of its competitors? The main competitors of Boston Scientific include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.

Boston Scientific vs.

Abbott Laboratories (NYSE:ABT) and Boston Scientific (NYSE:BSX) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

Abbott Laboratories presently has a consensus price target of $142.59, indicating a potential upside of 8.88%. Boston Scientific has a consensus price target of $114.52, indicating a potential upside of 11.01%. Given Boston Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Boston Scientific is more favorable than Abbott Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Abbott Laboratories
0 Sell rating(s)
4 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.84
Boston Scientific
0 Sell rating(s)
0 Hold rating(s)
22 Buy rating(s)
1 Strong Buy rating(s)
3.04

Abbott Laboratories has higher revenue and earnings than Boston Scientific. Abbott Laboratories is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abbott Laboratories$41.95B5.41$13.40B$7.7116.99
Boston Scientific$17.55B8.69$1.85B$1.3775.30

75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by insiders. Comparatively, 0.5% of Boston Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Abbott Laboratories has a net margin of 31.95% compared to Boston Scientific's net margin of 11.07%. Abbott Laboratories' return on equity of 20.74% beat Boston Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Abbott Laboratories31.95% 20.74% 11.19%
Boston Scientific 11.07%17.80%9.85%

In the previous week, Abbott Laboratories had 10 more articles in the media than Boston Scientific. MarketBeat recorded 49 mentions for Abbott Laboratories and 39 mentions for Boston Scientific. Abbott Laboratories' average media sentiment score of 1.27 beat Boston Scientific's score of 1.05 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Abbott Laboratories
38 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Boston Scientific
23 Very Positive mention(s)
2 Positive mention(s)
13 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Abbott Laboratories has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500.

Boston Scientific received 114 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 70.00% of users gave Abbott Laboratories an outperform vote while only 69.90% of users gave Boston Scientific an outperform vote.

CompanyUnderperformOutperform
Abbott LaboratoriesOutperform Votes
952
70.00%
Underperform Votes
408
30.00%
Boston ScientificOutperform Votes
1066
69.90%
Underperform Votes
459
30.10%

Summary

Abbott Laboratories beats Boston Scientific on 10 of the 18 factors compared between the two stocks.

Get Boston Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BSX vs. The Competition

MetricBoston ScientificSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$152.59B$4.33B$5.53B$18.96B
Dividend YieldN/A39.93%5.11%4.01%
P/E Ratio82.5330.0322.5932.87
Price / Sales8.6955.31401.3528.03
Price / Cash28.8651.0838.1817.52
Price / Book6.926.056.774.47
Net Income$1.85B$68.71M$3.22B$1.02B
7 Day Performance1.18%-0.24%1.39%0.59%
1 Month Performance3.09%-2.90%2.78%-3.54%
1 Year Performance43.22%21.00%15.85%3.80%

Boston Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BSX
Boston Scientific
4.0983 of 5 stars
$104.48
+1.2%
$114.52
+9.6%
+42.9%$154.66B$17.55B83.6545,000Analyst Upgrade
Positive News
ABT
Abbott Laboratories
4.8949 of 5 stars
$129.73
+0.7%
$142.59
+9.9%
+23.2%$224.89B$41.95B16.95115,000Positive News
ISRG
Intuitive Surgical
4.6185 of 5 stars
$514.65
+0.0%
$598.95
+16.4%
+39.1%$183.33B$8.71B80.3012,100Insider Trade
SYK
Stryker
4.8203 of 5 stars
$367.19
+0.6%
$423.53
+15.3%
+14.1%$140.18B$22.60B47.3351,000Earnings Report
Positive News
MDT
Medtronic
4.5496 of 5 stars
$84.07
-0.1%
$96.14
+14.4%
+3.1%$107.82B$33.20B25.5595,000Positive News
BDX
Becton, Dickinson and Company
4.9595 of 5 stars
$205.02
0.0%
$272.86
+33.1%
-27.5%$58.90B$20.64B34.0877,000Earnings Report
Dividend Announcement
Analyst Downgrade
News Coverage
Gap Down
EW
Edwards Lifesciences
4.6129 of 5 stars
$75.55
-0.6%
$79.45
+5.2%
-10.6%$44.37B$5.25B10.8317,300Short Interest ↓
Positive News
IDXX
IDEXX Laboratories
4.0405 of 5 stars
$435.59
-0.4%
$523.75
+20.2%
+0.7%$35.24B$3.90B40.7510,800Upcoming Earnings
Positive News
RMD
ResMed
4.0455 of 5 stars
$234.07
-0.8%
$258.83
+10.6%
+9.9%$34.40B$5.02B27.658,160Analyst Upgrade
Positive News
DXCM
DexCom
4.9112 of 5 stars
$71.28
-0.5%
$99.00
+38.9%
-44.2%$27.98B$4.03B49.907,600Earnings Report
News Coverage
Positive News
STE
STERIS
4.5034 of 5 stars
$225.97
+0.4%
$258.75
+14.5%
+8.4%$22.17B$5.40B47.9116,000Upcoming Earnings
Short Interest ↑
Positive News

Related Companies and Tools


This page (NYSE:BSX) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners